Nucleix Ltd.

Nucleix Ltd. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, their patients and the healthcare system. Our first product, Bladder EpiCheck®, is CE-marked in Europe for primary and recurrent bladder and upper tract urinary cancer, and FDA 510(k) cleared in the U.S. for bladder cancer recurrence. It is commercially available in both regions. Our global team operates from San Diego, California in the US and Rehovot, Israel.

Company Details

Employees
71
Address
Rehovot, Merkaz 76000, Il
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Rehovot, Merkaz
Looking for a particular Nucleix Ltd. employee's phone or email?

Nucleix Ltd. Questions

News

Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA 2025 - The AI Journal

Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA 2025 The AI Journal

FDA grants 510(k) clearance to Bladder EpiCheck for NMIBC surveillance - Urology Times

FDA grants 510(k) clearance to Bladder EpiCheck for NMIBC surveillance Urology Times

Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early - Fierce Biotech

Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early Fierce Biotech

Israel’s Nucleix gets funding from EU for lung-cancer kit - The Times of Israel

Israel’s Nucleix gets funding from EU for lung-cancer kit The Times of Israel

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe - 팜뉴스

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe 팜뉴스

Nucleix announces $22 million in funding, advancements in lung cancer detection program - CTech

Nucleix announces $22 million in funding, advancements in lung cancer detection program CTech

Data supports accuracy and performance of Nucleix’s Bladder Epicheck in NMIBC surveillance - BioWorld MedTech

Data supports accuracy and performance of Nucleix’s Bladder Epicheck in NMIBC surveillance BioWorld MedTech

Nucleix Earns FDA Nod for Non-Muscle Invasive Bladder Cancer Monitoring - Medical Product Outsourcing

Nucleix Earns FDA Nod for Non-Muscle Invasive Bladder Cancer Monitoring Medical Product Outsourcing

European study green-lights Israeli test for recurrence of bladder cancer - The Times of Israel

European study green-lights Israeli test for recurrence of bladder cancer The Times of Israel

BNO BIO invests $1M in Israeli biotech firm - BioSpectrum Asia

BNO BIO invests $1M in Israeli biotech firm BioSpectrum Asia

Israeli scientists find way to combat forged DNA - Phys.org

Israeli scientists find way to combat forged DNA Phys.org

Top Nucleix Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant